Thu Sep 19 07:24:30 UTC 2024: ## Rentokil Initial Downgraded Amid US Integration Challenges

**London, UK** – Leading pest control company Rentokil Initial Plc (LSE:RTO, NYSE:RTO) faced a downgrade from Redburn-Atlantic, shifting its rating from ‘Buy’ to ‘Neutral’ and adjusting its price target to GBP4.20. This decision comes on the heels of ongoing struggles with organic growth in the US, where integration efforts following the Terminix acquisition are proving more challenging than expected.

Rentokil’s US organic growth has remained stagnant after last year’s concerns, currently hovering around 1%. Redburn-Atlantic anticipates this sluggishness to continue, potentially impacting US organic growth by 40 to 100 basis points through 2026. As a result, the firm projects limited profit growth for the company from 2023 to 2026, with expected synergies being offset by lower volumes.

This downgrade echoes recent adjustments in Rentokil’s stock outlook. Oppenheimer reduced its price target to $30.00 from $35.00 while maintaining an ‘Outperform’ rating, citing slower organic growth in North America and expected cost escalations. CFRA, meanwhile, downgraded Rentokil from ‘Buy’ to ‘Hold’ following a profit warning and adjusted earnings per share estimates.

Despite these concerns, analysts acknowledge the company’s long-term growth potential. However, the path to realizing this value has become longer and more complex due to the integration challenges and current operating conditions.

Despite the downgrade, InvestingPro data reveals some positive aspects. Rentokil boasts impressive gross profit margins, indicating operational efficiency. The stock also trades at a low P/E ratio, suggesting potential undervaluation. Additionally, the Relative Strength Index (RSI) signals that the stock may be oversold, hinting at a potential rebound.

While the integration of Terminix and current economic conditions present challenges, Rentokil’s long-term value remains a point of optimism. Investors looking for a deeper dive into the company’s financial health and future prospects can explore further analysis on InvestingPro.com.

Read More